Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan. - Wikidata - awgldk - TriplyDB

Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan.

Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan.

http://www.wikidata.org/entity/Q34523396

about

Our explain to three doubts Chlorpromazine dose for people with schizophrenia.Evaluation of the individual safe correction of antipsychotic agent polypharmacy in Japanese patients with chronic schizophrenia: validation of safe corrections for antipsychotic polypharmacy and the high-dose method.Risk Factors for Tremor in a Population of Patients with Severe Mental Illness: An 18-year Prospective Study in a Geographically Representative Sample (The Curacao Extrapyramidal Syndromes Study XI).Antipsychotic combinations for schizophrenia.Catatonic Stupor in Schizophrenic Disorders and Subsequent Medical Complications and Mortality.

P2860

Q33858243-F6A2777D-4FFB-449C-94EA-6EBCA4057FCB Q34681498-C8D7D37E-A1C3-4AA0-8240-8B3F490AE412 Q35224262-3ACBB45B-74D0-43CA-BF32-5E7D4E857B99 Q38687222-D214EE4F-F389-4550-9E8C-B4B406A2BDB5 Q38704394-94C59C79-C566-4592-A14E-DE9874211392 Q55401438-F9CB9A94-E53E-4BE2-AD7D-C25C16630741

P2860

Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan.

http://www.wikidata.org/entity/Q34523396

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan.

@ast

Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan.

@en

Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan.

@nl

type

label

Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan.

@ast

Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan.

@en

Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan.

@nl

prefLabel

Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan.

@ast

Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan.

@en

Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan.

@nl

P1433

Q34523396-429A9649-445F-4B91-9FFE-F72A7C9D5D87

P1476

Q34523396-C6999685-5D5A-4A1D-AB52-6E6188EDB1E3

P2093

Q34523396-0A15C8BC-3DF3-4B86-9491-608F4D594A62

Q34523396-1268FD8B-E823-4F5E-B993-3F13B42B9BF3

Q34523396-1356BB9B-6950-47EB-8AF9-DCE11B55600F

Q34523396-57C03F64-FC17-4AD7-9741-C378DF621B6A

Q34523396-934F1AAA-DBCC-43D7-B7DD-32E27C380018

Q34523396-B2D3FEB2-CD90-4B51-8DFA-CA449C59D352

P2860

Q34523396-0A2F117F-47BE-489D-A8AC-89D41A0A4A9F

Q34523396-1438F90C-66EA-4BD5-9336-C951A82FE4D9

Q34523396-17AC2B88-35B5-4566-8A28-5FE028B6C1DB

Q34523396-28B5DA55-1FB6-4786-88E4-CF258F6F0332

Q34523396-6707847E-2BEC-4BF4-8FF1-B74876E37B1C

Q34523396-E89B8BB7-BD80-4E1D-B495-55B1C9DC4570

Q34523396-EA6AC98C-E062-4E2D-8F68-86F30B99EE89

P2888

Q34523396-A3EC85E5-A897-43A9-B862-C92F1CDDF935

P304

Q34523396-269235F8-E0FA-4E00-83E7-953B41E38104

P31

Q34523396-2AD1D70B-A436-42E2-A85C-321A256F8FCD

P356

Q34523396-07818A7F-190D-47EF-B4FF-5580C3554BAD

P478

Q34523396-701E89CA-4582-40FB-B6B9-F8F59F9C3AEA

P50

Q34523396-199697E1-B521-4359-B5C4-C94832EDD04A

P577

Q34523396-127C4265-3D7B-48E6-82C0-8945E5908064

P6179

Q34523396-3036F32E-A17E-450B-B897-80201F3C0688

P698

Q34523396-DB9A802E-8E81-4463-B4B1-BE3B7A4B3AF8

P932

Q34523396-911C82AA-74E0-469A-BE01-04ACF8ED6110

P356

1471-244X-14-103

P1433

P1476

Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan

@en

P2093

Ataru Inagaki

http://www.w3.org/2001/XMLSchema#string

Reiji Yoshimura

http://www.w3.org/2001/XMLSchema#string

Takashi Yoshio

http://www.w3.org/2001/XMLSchema#string

Toshiya Inada

http://www.w3.org/2001/XMLSchema#string

Tsuruhei Sukegawa

http://www.w3.org/2001/XMLSchema#string

Yoshio Yamanouchi

http://www.w3.org/2001/XMLSchema#string

P2860

Influence of antipsychotics on mortality in schizophrenia: systematic review.

Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics.

Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009.

Prescription profiles for pharmacological treatment of Japanese inpatients with schizophrenia: comparison between 2007 and 2009.

Estimating an EQ-5D population value set: the case of Japan.

High dose antipsychotic use in schizophrenia: findings of the REAP (research on east Asia psychotropic prescriptions) study.

Brief assessment of cognition in schizophrenia: validation of the Japanese version.

P2888

1471-244x-14-103

P304

103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-244X-14-103

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1020956979

http://www.w3.org/2001/XMLSchema#string

P698

24708857

http://www.w3.org/2001/XMLSchema#string

P932

4234191

http://www.w3.org/2001/XMLSchema#string